Multiple myeloma dell-derived microvesicles are enriched in CD147 expression and enhance tumor cell proliferation

Bonnie K. Arendt, Denise K. Walters, Xiaosheng Wu, Renee C. Tschumper, Diane F. Jelinek

Research output: Contribution to journalArticlepeer-review

44 Scopus citations


Multiple myeloma (MM) is characterized by the clonal expansion of malignant plasma cells within the bone marrow. There is a growing literature that tumor cells release biologically active microvesicles (MVs) that modify both local and distant microenvironments. In this study, our goals were to determine if MM cells release MVs, and if so, begin to characterize their biologic activity. Herein we present clear evidence that not only do both patient MM cells and human MM cell lines (HMCLs) release MVs, but that these MVs stimulate MM cell growth. Of interest, MM-derived MVs were enriched with the biologically active form of CD147, a transmembrane molecule previously shown by us to be crucial for MM cell proliferation. Using MVs isolated from HMCLs stably transfected with a CD147-GFP fusion construct (CD147GFP), we observed binding and internalization of MV-derived CD147 with HMCLs. Cells with greater CD147GFP internalization proliferated at a higher rate than did cells with less CD147GFP association. Lastly, MVs obtained from CD147 downregulated HMCLs were attenuated in their ability to stimulate HMCL proliferation. In summary, this study demonstrates the significance of MV shedding and MV-mediated intercellular communication on malignant plasma cell proliferation, and identifies the role of MV-enriched CD147 in this process.

Original languageEnglish (US)
Pages (from-to)5686-5699
Number of pages14
Issue number14
StatePublished - 2014


  • Differentiation
  • E-cadherin
  • HDAC
  • MPT0G030
  • PKCd

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Multiple myeloma dell-derived microvesicles are enriched in CD147 expression and enhance tumor cell proliferation'. Together they form a unique fingerprint.

Cite this